News 28 Giu 2023 Innovative Western Switzeland start-ups take center stage in global awards Start-ups WattAnyWhere, Enhance-d, and Neur.on win big in global awards thanks to their pioneering technologies in cleantech, healthcare, and leg...
News 14 Mar 2023 CSEM leads the industrialization of HiFiBiO’s complex microfluidic chips HiFiBiO Therapeutics and CSEM are collaborating to create and produce single-cell microfluidics, which have the potential to revolutionize immuno...
News 19 Apr 2023 Three Valais start-ups in the finals of the prestigious Venture competition Valais-based start-ups Zizania Biobotanica, Qaptis, and Veintree are competing for the prestigious Venture award and the CHF 150,000 prize promis...
Actualités 06 Ott 2020 SOPHiA GENETICS lève 110 millions de dollars Leader mondial de la médecine basée sur les données, SOPHiA GENETICS a conclu un tour de financement de 110 millions de dollars pour entrer dans ...
News 16 Gen 2023 Geneva start-up STALICLA signs exclusive in-licensing agreement with Novartis STALICLA has acquired global rights for Novartis' drug candidate mavoglurant, a treatment for substance-use disorders and neurodevelopmental diso...
News 23 Nov 2022 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
News 26 Mag 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 13 Feb 2023 Hôpital de La Tour will invest CHF 750 million to create a health campus in Geneva Leading private healthcare facility Hôpital de la Tour has entered into a CHF 750 million agreement to create a major health campus project to pr...